CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Merck & Co Inc - USD - MRK CFD

104.68
0.57%
0.31
Rendah: 102.55
Tinggi: 104.81
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.31
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Merck & Co Inc ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

Key Stats
Prev. Close* 104.09
Open* 103.92
1-Year Change* 30.5%
Day's Range* 102.55 - 104.81
52 wk Range 80.45-115.49
Average Volume (10 days) 11.09M
Average Volume (3 months) 178.07M
Market Cap 266.04B
P/E Ratio 18.34
Shares Outstanding 2.54B
Revenue 59.28B
EPS 5.71
Dividend (Yield %) 2.78626
Beta 0.36
Next Earnings Date Apr 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 24, 2023 104.68 1.26 1.22% 103.42 104.91 102.33
Mar 23, 2023 104.09 0.16 0.15% 103.93 104.53 103.35
Mar 22, 2023 104.31 -0.36 -0.34% 104.67 105.89 104.23
Mar 21, 2023 105.48 0.12 0.11% 105.36 106.32 104.63
Mar 20, 2023 105.74 1.98 1.91% 103.76 106.80 103.75
Mar 17, 2023 103.98 -2.93 -2.74% 106.91 107.20 103.39
Mar 16, 2023 107.20 1.35 1.28% 105.85 107.60 104.00
Mar 15, 2023 107.37 1.94 1.84% 105.43 107.92 105.41
Mar 14, 2023 106.75 1.80 1.72% 104.95 107.03 104.43
Mar 13, 2023 105.57 1.26 1.21% 104.31 108.74 103.92
Mar 10, 2023 107.56 0.42 0.39% 107.14 110.63 106.66
Mar 9, 2023 107.55 -1.61 -1.47% 109.16 109.76 106.91
Mar 8, 2023 108.10 -2.61 -2.36% 110.71 111.17 107.48
Mar 7, 2023 111.17 0.56 0.51% 110.61 112.05 110.47
Mar 6, 2023 110.99 4.08 3.82% 106.91 111.14 106.73
Mar 3, 2023 106.72 0.21 0.20% 106.51 107.28 105.99
Mar 2, 2023 106.91 1.04 0.98% 105.87 107.28 105.87
Mar 1, 2023 106.54 0.83 0.79% 105.71 107.44 105.24
Feb 28, 2023 106.11 -1.98 -1.83% 108.09 108.46 106.02
Feb 27, 2023 109.27 -0.23 -0.21% 109.50 109.96 108.42

Merck & Co Inc - USD Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 48704 41518 39121 42294 40122
Revenue 48704 41518 39121 42294 40122
Cost of Revenue, Total 13241 11583 11060 13065 12640
Gross Profit 35463 29935 28061 29229 27482
Total Operating Expense 36166 36545 31821 33995 34101
Selling/General/Admin. Expenses, Total 9615 8908 9421 10067 10028
Research & Development 10281 10102 8555 7854 7495
Unusual Expense (Income) 3029 5952 2785 3009 3938
Operating Income 12538 4973 7300 8299 6021
Interest Income (Expense), Net Non-Operating 873 421 -636 10 -116
Other, Net 468 469 507 392 616
Net Income Before Taxes 13879 5863 7171 8701 6521
Net Income After Taxes 12358 4523 5606 6482 5043
Minority Interest -13 -4 84 27 -24
Net Income Before Extra. Items 12345 4519 5690 6509 5019
Net Income 13049 7067 9843 6220 2394
Income Available to Common Excl. Extra. Items 12345 4519 5690 6509 5019
Income Available to Common Incl. Extra. Items 13049 7067 9843 6220 2394
Diluted Net Income 13049 7067 9843 6220 2394
Diluted Weighted Average Shares 2538 2541 2580 2679 2748
Diluted EPS Excluding Extraordinary Items 4.86407 1.77843 2.20543 2.42964 1.82642
Dividends per Share - Common Stock Primary Issue 2.64 2.48 2.26 1.99 2.36
Diluted Normalized EPS 6.81007 4.69927 3.96379 4.13343 4.03264
Total Extraordinary Items 704 2548 4153 -289 -2625
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 15901 13521 13154 11402 10627
Revenue 15901 13521 13154 11402 10627
Cost of Revenue, Total 5334 3827 3402 3029 2984
Gross Profit 10567 9694 9752 8373 7643
Total Operating Expense 10332 9946 8338 9788 8095
Selling/General/Admin. Expenses, Total 2302 2820 2331 2279 2185
Research & Development 2569 3061 2437 2611 2404
Unusual Expense (Income) 127 238 168 1869 522
Operating Income 5569 3575 4816 1614 2532
Interest Income (Expense), Net Non-Operating -983 110 448 -27 345
Other, Net 275 224 2 130 110
Net Income Before Taxes 4861 3909 5266 1717 2987
Net Income After Taxes 4307 3824 4571 1214 2749
Minority Interest 3 -4 -4 -1 -4
Net Income Before Extra. Items 4310 3820 4567 1213 2745
Total Extraordinary Items 0 -62 0 332 434
Net Income 4310 3758 4567 1545 3179
Income Available to Common Excl. Extra. Items 4310 3820 4567 1213 2745
Income Available to Common Incl. Extra. Items 4310 3758 4567 1545 3179
Diluted Net Income 4310 3758 4567 1545 3179
Diluted Weighted Average Shares 2537 2535 2536 2540 2540
Diluted EPS Excluding Extraordinary Items 1.69886 1.5069 1.80087 0.47756 1.08071
Dividends per Share - Common Stock Primary Issue 0.69 0.69 0.65 0.65 0.65
Diluted Normalized EPS 1.52074 1.9997 2.01068 1.13784 1.44992
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 30266 27764 27483 25875 24766
Cash and Short Term Investments 8096 8062 10450 8864 8498
Cash & Equivalents 8096 8062 9676 7965 6092
Short Term Investments 0 774 899 2406
Total Receivables, Net 9230 7851 6778 7071 6873
Accounts Receivable - Trade, Net 9230 7851 6778 7071 6873
Total Inventory 5953 6310 5978 5440 5096
Other Current Assets, Total 6987 5541 4277 4500 4299
Total Assets 105694 91588 84397 82637 87872
Property/Plant/Equipment, Total - Net 19279 17986 16126 13291 12439
Property/Plant/Equipment, Total - Gross 37471 36968 33812 29615 29041
Accumulated Depreciation, Total -18192 -18982 -17686 -16324 -16602
Goodwill, Net 21264 20238 19425 18253 18284
Intangibles, Net 22933 14604 14196 11431 14183
Long Term Investments 966 1371 1889 6233 12892
Other Long Term Assets, Total 10986 9625 5278 7554 5308
Total Current Liabilities 23872 27327 22220 22206 18614
Accounts Payable 4609 4594 3738 3318 3102
Accrued Expenses 13859 13053 12453 10073 10263
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2412 6431 3610 5308 3057
Other Current Liabilities, Total 2992 3249 2419 3507 2192
Total Liabilities 67510 66271 58490 55936 53536
Total Long Term Debt 30690 25360 22736 19806 21353
Long Term Debt 30690 25360 22736 19806 21353
Deferred Income Tax 3441 1015 1470 1702 2219
Minority Interest 73 87 94 181 233
Other Liabilities, Total 9434 12482 11970 12041 11117
Total Equity 38184 25317 25907 26701 34336
Common Stock 1788 1788 1788 1788 1788
Additional Paid-In Capital 44238 39588 39660 38808 39902
Retained Earnings (Accumulated Deficit) 53696 47362 46602 42579 41350
Treasury Stock - Common -57109 -56787 -55950 -50929 -43794
Unrealized Gain (Loss) 0 0 18 -78 -61
Other Equity, Total -4429 -6634 -6211 -5467 -4849
Total Liabilities & Shareholders’ Equity 105694 91588 84397 82637 87872
Total Common Shares Outstanding 2527.6 2530.23 2539.02 2592.56 2696.61
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 31184 30266 31058 28665 26909
Cash and Short Term Investments 8928 8096 10016 8575 6981
Cash & Equivalents 8556 8096 10016 8575 6981
Total Receivables, Net 9828 9230 8571 7843 8235
Accounts Receivable - Trade, Net 9828 9230 8571 7843 8235
Total Inventory 5774 5953 5603 5499 6402
Other Current Assets, Total 6654 6987 6868 6748 5291
Total Assets 106668 105694 93494 90688 90847
Property/Plant/Equipment, Total - Net 19747 19279 18565 18064 18295
Property/Plant/Equipment, Total - Gross 38245 37471 36720 36300 37027
Accumulated Depreciation, Total -18498 -18192 -18155 -18236 -18732
Goodwill, Net 21258 21264 18862 18873 20212
Intangibles, Net 23022 22933 13384 13622 14401
Long Term Investments 959 966 1013 1105 1195
Other Long Term Assets, Total 10498 10986 10612 10359 9835
Total Current Liabilities 22316 23872 23728 21906 26361
Accounts Payable 3715 4609 3366 3897 4034
Accrued Expenses 14051 13859 14214 12888 11911
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1208 2412 3534 2488 7251
Other Current Liabilities, Total 3342 2992 2614 2633 3165
Total Liabilities 65785 67510 57700 57394 63902
Total Long Term Debt 30586 30690 22907 24033 24002
Long Term Debt 30586 30690 22907 24033 24002
Deferred Income Tax 3071 3441 1527 1489 1204
Minority Interest 70 73 69 94 94
Other Liabilities, Total 9742 9434 9469 9872 12241
Total Equity 40883 38184 35794 33294 26945
Common Stock 1788 1788 1788 1788 1788
Additional Paid-In Capital 44275 44238 44149 44039 39613
Retained Earnings (Accumulated Deficit) 56252 53696 51691 48777 48888
Treasury Stock - Common -57063 -57109 -57244 -56682 -56722
Unrealized Gain (Loss) 0 0 0 0
Other Equity, Total -4369 -4429 -4590 -4628 -6622
Total Liabilities & Shareholders’ Equity 106668 105694 93494 90688 90847
Total Common Shares Outstanding 2528.38 2527.6 2525.32 2532.75 2531.3
Short Term Investments 372
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 12358 4523 9777 6193 2418
Cash From Operating Activities 14109 10253 13440 10922 6447
Cash From Operating Activities 1578 1669 3652 4519 4637
Deferred Taxes 187 -566 -556 -509 -2621
Non-Cash Items 2189 7411 2634 2272 7034
Cash Taxes Paid 2400 2700 4500 1500 4900
Cash Interest Paid 779 822 841 777 723
Changes in Working Capital -3839 -4601 -2067 -1553 -5021
Cash From Investing Activities -16555 -9443 -2629 4314 2679
Capital Expenditures -4448 -4429 -3473 -2615 -1888
Other Investing Cash Flow Items, Total -12107 -5014 844 6929 4567
Cash From Financing Activities 2593 -2832 -8861 -13160 -10006
Financing Cash Flow Items 8210 -436 5 -325 -195
Total Cash Dividends Paid -6610 -6215 -5695 -5172 -5167
Issuance (Retirement) of Stock, Net -638 -1192 -4419 -8500 -3515
Issuance (Retirement) of Debt, Net 1631 5011 1248 837 -1129
Foreign Exchange Effects -133 253 17 -205 457
Net Change in Cash 14 -1769 1967 1871 -423
Amortization 1636 1817
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 4307 12358 8534 3963 3186
Cash From Operating Activities 4761 14109 9078 4281 1791
Cash From Operating Activities 421 1578 1148 749 396
Amortization 699 1636 1231 871 534
Deferred Taxes -338 187 28 29 -10
Non-Cash Items 971 2189 1931 2324 -211
Cash Interest Paid 211 779 570 363 217
Changes in Working Capital -1299 -3839 -3794 -3655 -2104
Cash From Investing Activities -1173 -16555 -4506 -3445 -738
Capital Expenditures -984 -4448 -3240 -2068 -1134
Other Investing Cash Flow Items, Total -189 -12107 -1266 -1377 396
Cash From Financing Activities -3086 2593 -2614 -340 -2098
Financing Cash Flow Items -103 8210 8243 8302 -97
Total Cash Dividends Paid -1745 -6610 -4967 -3318 -1645
Issuance (Retirement) of Stock, Net 12 -638 -754 -188 9
Issuance (Retirement) of Debt, Net -1250 1631 -5136 -5136 -365
Foreign Exchange Effects -55 -133 -65 -19 -97
Net Change in Cash 447 14 1893 477 -1142
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.9028 226006835 3029294 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.4668 138780980 943188 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.6467 117961857 650528 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.443 62016871 21859699 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9042 48339275 238356 2022-12-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 1.1809 29977649 -972799 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.0486 26619794 4144762 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9715 24662395 875494 2022-12-31 LOW
BofA Global Research (US) Research Firm 0.9181 23307976 1126317 2022-12-31 LOW
MFS Investment Management Investment Advisor/Hedge Fund 0.908 23049712 -3083441 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 0.9056 22988508 11024368 2022-12-31 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.8679 22032201 106275 2022-12-31 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7559 19189617 -514995 2022-12-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.7283 18487766 58083 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7216 18318918 227150 2022-12-31 LOW
BlackRock Asset Management Ireland Limited Investment Advisor 0.7102 18029190 921784 2022-12-31 LOW
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.69 17517281 -601837 2022-12-31 LOW
Managed Account Advisors LLC Investment Advisor 0.6654 16892241 -933629 2022-12-31 LOW
Nuveen LLC Pension Fund 0.6271 15920764 2664291 2022-12-31 LOW
Mellon Investments Corporation Investment Advisor/Hedge Fund 0.59 14978749 -2123527 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Pharmaceuticals (NEC)

2000 Galloping Hill Road
KENILWORTH
NEW JERSEY 07033
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

27,875.10 Price
+1.710% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

US100

12,798.80 Price
+0.420% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 3.0

Gold

1,978.85 Price
-0.760% 1D Chg, %
Biaya inap posisi Long -0.0179%
Biaya inap posisi short 0.0097%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

XRP/USD

0.45 Price
-1.050% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00390

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda